AM

Healthcare · Pharmaceuticals

Amrutanjan Health Care Ltd (AMRUTANJAN)

₹512.65

Mkt cap
₹1,482 Cr
P/E ratio
22.60
P/B
3.85
Div yield
0.96%
ROE
18.40%
ROCE
24.80%
EPS (TTM)
₹22.68
Book value
₹133
52W range
477–726
Sector
Healthcare

Price history

Previous close

AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink. [1]

NSE AMRUTANJANBSE 590006
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsBearish
52-week range
−29.35% from high
₹513
₹477+7.59% from low₹726
Current
₹512.65
Prev close
₹517.05
Day
−0.85%
Price performance
1D
−0.49%
1W
+1.19%
1M
+3.52%
3M
−1.37%
6M
−6.33%
1Y
−28.53%
YTD
−23.80%

Financials

Revenue, profit & margin
P/E ratio
22.6×
AMRUTANJAN is 30% below the sector median of 32.5×
AMRUTANJAN22.6×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales991171278411012313594118141150103135
YoY Sales growth-10%+20%+27%+8%+11%+5%+7%+12%+7%+15%+11%+9%+15%
Expenses92951118096991188610111612497112
Operating Profit7221641423188172526624
OPM %7%18%13%4.2%12%19%13%9%14%18%17%6%17%
Other Income4454445443-323
Interest0000000000000
Depreciation2222222222223
Profit before tax92420616262111192621623
Tax %26%26%30%27%26%26%27%26%27%26%23%28%25%
Net Profit7171451219158141916417
EPS in Rs2.376.044.721.604.086.665.252.874.836.735.601.515.98
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.75% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast11 Aug '26◦3 Nov '26◦
Earnings day−8.51%+3.00%
+1 day−7.90%+4.08%
+5 days−6.55%+2.10%
+15 days−6.28%—
+30 days−4.41%—
FilingXBRLXBRL

Corporate actions

Last 6 months
KindValueEx-dateRecord
dividend
Interim Dividend - Re 1 Per Share
—6 Nov '267 Nov '26

Shareholding

as of Sep 2026
46.52%Promoter
Promoters46.52%
FIIs3.47%1.03
DIIs6.90%5.39
Public43.08%4.36
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Amrutanjan Healt₹512.6522.621,4820.96%17+23.78%135+14.85%24.84%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings